Humacyte, Inc.

Humacyte makes artificial blood vessels from human tissue that doctors can implant into patients to repair or replace damaged veins and arteries. The company grows these vessels in a lab using a process that removes cells, leaving behind a structure the body accepts without triggering an immune rejection. The vessels are being developed to treat conditions like blocked arteries, kidney disease requiring dialysis access, and heart surgery in children, as well as to help deliver cell transplants for treating Type 1 diabetes.